List of works - Daniel A Goldstein

Cabozantinib for patients with advanced hepatocellular carcinoma: a cost-effectiveness analysis

scientific article published on 23 September 2019

Clinical Utility of Routine Cardiac Monitoring in Breast Cancer Patients Receiving Trastuzumab

scientific article published on 15 June 2016

Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer

scientific article published on 24 August 2015

Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma

scientific article

Duration of adjuvant immunotherapy-biologic, clinical and economic considerations

scientific article published on 29 October 2018

Economics of ramucirumab for metastatic colorectal cancer

scientific article published on 9 November 2016

Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19

scientific article published on 24 December 2020

Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma

scientific article published on 25 October 2017

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis

scientific article published on 17 February 2015

Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer

scientific article published on 26 March 2013

International health in medical education: students' experiences and views

scientific article published on January 2007

Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?

scientific article published on 29 June 2017

Reply to A. Messori et al, R. Bordonaro et al, and G. Fasola et al

scientific article published on 24 August 2015

Reply to Á. Benedict et al

scientific article published on 17 July 2017

Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab-Letter

scientific article published on 01 May 2020

Should every candidate for cataract extraction be scheduled to the preoperative clinic? The Rabin Medical Center experience

scientific article published on 29 July 2019

The Financial Impact of Hypofractionated Radiation for Localized Prostate Cancer in the United States

scientific article published on 02 January 2019

The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real-world early-stage breast cancer

scientific article published on 06 May 2020

Time Is Money: Optimizing the Scheduling of Nivolumab

scientific article published on 27 August 2018

Trajectories of Injectable Cancer Drug Costs After Launch in the United States

scientific article published on 10 October 2017

Using Quality-Adjusted Life-Years in Cost-Effectiveness Analyses: Do Not Throw Out the Baby or the Bathwater

scientific article published on 03 May 2016

List of works by Daniel A Goldstein